O

Ossur hf
CSE:OSSR

Watchlist Manager
Ossur hf
CSE:OSSR
Watchlist
Price: 26.4 DKK -2.22% Market Closed
Market Cap: kr11.3B

P/FCFE

22.5
Current
2%
More Expensive
vs 3-y average of 22.1

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
22.5
=
Market Cap
kr11.3B
/
Free Cash Flow to Equity
$79.2m

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
22.5
=
Market Cap
kr11.3B
/
Free Cash Flow to Equity
$79.2m

Valuation Scenarios

Ossur hf is trading above its 3-year average

If P/FCFE returns to its 3-Year Average (22.1), the stock would be worth kr26 (1% downside from current price).

Statistics
Positive Scenarios
1/4
Maximum Downside
-22%
Maximum Upside
+2%
Average Downside
6%
Scenario P/FCFE Value Implied Price Upside/Downside
Current Multiple 22.5 kr26.4
0%
3-Year Average 22.1 kr26
-1%
5-Year Average 23 kr27.01
+2%
Industry Average 22.1 kr26.01
-1%
Country Average 17.5 kr20.6
-22%

Forward P/FCFE
Today’s price vs future free cash flow to equity

Not enough data available to calculate forward P/FCFE

Peer Comparison

All Multiples
P/FCFE
P/E
All Countries
Close
Market Cap P/FCFE P/E
IS
Ossur hf
CSE:OSSR
11.3B DKK 22.5 31.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
162.6B USD 65.3 56.9
US
Abbott Laboratories
NYSE:ABT
155.4B USD 29 24.8
US
Stryker Corp
NYSE:SYK
112.7B USD 20.7 34.7
IE
Medtronic PLC
NYSE:MDT
102.7B USD 27.3 22.3
US
Boston Scientific Corp
NYSE:BSX
83.8B USD 29.3 23.5
US
Edwards Lifesciences Corp
NYSE:EW
48.8B USD 37 44.5
DE
Siemens Healthineers AG
XETRA:SHL
39.3B EUR 41.4 18.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.2B USD 46 42.7
US
Becton Dickinson and Co
NYSE:BDX
42.5B USD 17.6 24.2
US
Resmed Inc
NYSE:RMD
29.9B USD 17.2 20.1

Market Distribution

Higher than 78% of companies in Iceland
Percentile
78th
Based on 20 companies
78th percentile
22.5
Low
3 — 10.7
Typical Range
10.7 — 22.1
High
22.1 —
Distribution Statistics
Iceland
Min 3
30th Percentile 10.7
Median 17.5
70th Percentile 22.1
Max 109

Ossur hf
Glance View

Market Cap
11.3B DKK
Industry
Health Care

Össur hf. is an Icelandic company that stands as a quiet marvel in the realm of orthopedic innovation, specializing in the development of non-invasive equipment designed to enhance human mobility. Born out of a small prosthetics shop in Reykjavik in 1971, the company has grown into a global leader in orthopedic solutions. At its core, Össur's operations revolve around the invention and commercialization of cutting-edge prosthetics, braces, and supports aimed at improving the quality of life for people who face limb challenges due to injuries, disabilities, or age-related conditions. The company's ethos of "Life Without Limitations" guides its pursuit to blend medical technology and engineering in a way that restores human dignity and functionality, manifesting a unique synergy between advanced robotics and biology. Commercially, Össur thrives by leveraging its commitment to research and development, channeling substantial investment into creating high-demand products characterized by reliability, adaptability, and innovation. Revenue streams primarily flow from the sale of prosthetic limbs and associated components, together with orthopedic support products that are distributed both directly and through a network of wholesalers and medical professionals worldwide. By maintaining a diversified product line and focusing on customer-centric customization, Össur meets a significant demand within healthcare systems, insurance providers, and direct consumer markets. The company's ability to translate its scientific prowess into marketable and life-enhancing solutions has cemented its reputation as a key player in the med-tech industry, aligning financial success with a meaningful social mission.

OSSR Intrinsic Value
Not Available
O
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett